Oncology Account Executive

Overview

Ready to redefine what's possible in molecular diagnostics? Join a team of innovators at BillionToOne, a category-defining company on Nasdaq where transparency fuels trust and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. We build products that are 10x better than what exists today and are driven by a commitment to changing the standard of care in prenatal and cancer diagnostics.

We are looking for a field-based professional Oncology Account Executive, Columbus North with scientific and clinical expertise to support our oncology portfolio of liquid biopsy products. The position is responsible for driving sales volume for BillionToOne’s Northstar Liquid biopsy products and services, while cultivating relationships with oncologists and other members of the extended cancer care community in the designated geography. The Oncology Account Executive is a field based position and reports to a Regional Manager - Oncology.

Responsibilities

• Increasing revenue and driving market development through direct sales to individual oncologists
• Creating and implementing a strategic business plan to grow revenue quickly in your geography
• Sales efforts include effective prospecting and cultivating new business and maintaining key relationships

Qualifications

• Bachelor's Degree or equivalent experience
• Demonstrated successful sales track record (e.g., Presidents club, Chairman's club, Rookie of the Year, or a history of success - at or above goal for multiple quarters/years)
• Experience selling to medical providers
• Experience selling medical diagnostics, medical or surgical devices
• Lives within the defined territory and centrally located to defined accounts
• Commitment to travel within defined territory
• Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers
• Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required
• Exceptionally bright, flexible, self-motivated and results oriented with strong interpersonal and analytical skills and the ability to think strategically as well as execute tactically
• Must act with a sense of urgency, with a focus on closing business
• Ability to assess the needs of medical professionals and staff members with a focus on consultative sales, coordination of logistics, and problem solving
• Strong desire to work in a startup environment and must work independently with an internal drive to be successful

We will also consider candidates with the following backgrounds

• Physicians Assistant (PA), Nurse Practitioner (NP) or Registered Nurse (RN) with experience ordering late stage cancer liquid biopsy tests
• Working alongside brilliant, kind, passionate and dedicated colleagues, in an empowering environment, toward a global vision, striving for a future in which transformative molecular diagnostics can help millions of patients
• Open, transparent culture that includes weekly Town Hall meetings
• The ability to indirectly or directly change the lives of hundreds of thousand patients
• Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered up to 80%
• Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
• Supplemental fertility benefits coverage
• Retirement savings program including a 4% Company match
• Increase paid time off with increased tenure
• Latest and greatest hardware (laptop, lab equipment, facilities)

At BillionToOne, we are proud to offer a combination of a base pay + uncapped commissions, generous equity options, and industry-leading company benefits.

For this position, we offer a total compensation range of $241,946 - $311,536 per year (at plan), including a base salary range of $168,346 - $184,186 per year (based on the level and experience). Commission potential is uncapped and can be significant.

BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

For more information about how we protect your information, we encourage you to review our Privacy Policy.

About BillionToOne

BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. Our revolutionary QCT molecular counting technology enhances disease detection resolution by over a thousandfold using cell-free DNA, a breakthrough that has already transformed the lives of over half a million patients worldwide.

Our Impact

Unity Complete is the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Our Northstar liquid biopsy test uniquely combines treatment selection with real-time monitoring, giving oncologists unprecedented precision in cancer care.

Our Growth

From $0 to $150M+ in Annual Recurring Revenue in just five years. In 2025, we completed one of the most successful IPOs for a medical diagnostics company, building on nearly $400M in private funding, including our $130M Series D in 2024 and backed by world-class investors including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest.

Our Recognition

Forbes named us one of America's Best Startup Employers for 2025 and we're Great Place to Work certified, with 100% of our people willing to go the extra mile, even as we've scaled to over 700 employees.

Our Future

Headquartered in Menlo Park with facilities in Union City, CA, and a new lab opening in Austin, TX in 2027, we're continuing to push the boundaries of what's possible in molecular diagnostics. We're just getting started.

Ready to help us change the world, one molecule at a time? Learn more at billiontoone.com